JFS Wealth Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16K Buy
74
+6
+9% +$1.15K ﹤0.01% 830
2026
Q1
$12.5K Buy
68
+5
+8% +$921 ﹤0.01% 867
2025
Q4
$11.1K Buy
63
+58
+1,160% +$9.48K ﹤0.01% 937
2025
Q3
$701 Hold
5
﹤0.01% 1694
2025
Q2
$628 Buy
5
+2
+67% +$249 ﹤0.01% 1657
2025
Q1
$411 Sell
3
-3
-50% -$429 ﹤0.01% 1793
2024
Q4
$918 Sell
6
-45
-88% -$7.59K ﹤0.01% 1683
2024
Q3
$9.89K Sell
51
-7
-12% -$1.46K ﹤0.01% 860
2024
Q2
$13.4K Sell
58
-5
-8% -$1.09K ﹤0.01% 704
2024
Q1
$13.6K Sell
63
-16
-20% -$3.75K ﹤0.01% 720
2023
Q4
$20.4K Hold
79
﹤0.01% 577
2023
Q3
$20.3K Hold
79
﹤0.01% 547
2023
Q2
$22.5K Hold
79
﹤0.01% 520
2023
Q1
$22K Sell
79
-13
-14% -$3.6K ﹤0.01% 515
2022
Q4
$25.5K Buy
92
+5
+6% +$1.41K ﹤0.01% 481
2022
Q3
$23K Buy
87
+42
+93% +$8.92K ﹤0.01% 541
2022
Q2
$9K Sell
45
-15
-25% -$3.07K ﹤0.01% 783
2022
Q1
$13K Buy
60
+39
+186% +$8.48K ﹤0.01% 704
2021
Q4
$5K Buy
+21
New +$5.4K ﹤0.01% 784
2015
Q1
Sell
-55
Closed -$19K 510
2014
Q4
$19K Buy
+55
New +$17.8K ﹤0.01% 291

Other funds holding BIIB

JFS Wealth Advisors's BIIB Position: Q2 2026 in Review

JFS Wealth Advisors increased its Biogen (BIIB) stake by 8.8% in Q2 2026, buying an estimated $1.15K and bringing the position to 74 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #830.

JFS Wealth Advisors first reported a position in BIIB in Q4 2014 and has held it in 20 quarters since. The position peaked at $25.5K in Q4 2022. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • JFS Wealth Advisors held 74 shares of Biogen worth $16K as of Q2 2026.
  • JFS Wealth Advisors bought 6 Biogen shares in Q2 2026, an estimated $1.15K.
  • Biogen made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #830 holding.
  • JFS Wealth Advisors first reported a position in Biogen in Q4 2014 and has held it in 20 quarters since.
  • JFS Wealth Advisors's Biogen position peaked at $25.5K in Q4 2022.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.